Diligence memo · auto-generated · as of July 2, 2026
Star Therapeutics LLC
Star Therapeutics LLC has raised $125M over 1 round; too few niche peers to rank its valuation yet.
Businessfiled
Star Therapeutics LLC operates in Pharma, based in SOUTH SAN FRANCISCO.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Star Therapeutics LLC has raised $125M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $125M on 2025-09-22.
Most recent recorded round closed around 2025-09-22.
Valuation (modeled)modeled
Provath models Star Therapeutics LLC at approximately $936M (range $595M–$1.1B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Last raise 9 mo ago; this sector typically re-raises about every 16 months.
Raising on or ahead of the sector's normal rhythm.
Comparablesmixed
Capital scale ranks ahead of 93% of Pharma peers (310 compared).
Modeled value ranks above 90% of those peers.
Closest niche peers: Cognito Therapeutics Group, Inc., Affinia Therapeutics Inc..
Peoplefiled
12 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.